Paper
10 June 2022 Application of bionanomaterials for cancer therapy
Zongzheng Wang
Author Affiliations +
Proceedings Volume 12179, Second International Conference on Medical Imaging and Additive Manufacturing (ICMIAM 2022); 121790I (2022) https://doi.org/10.1117/12.2637325
Event: Second International Conference on Medical Imaging and Additive Manufacturing (ICMIAM 2022), 2022, Xiamen, China
Abstract
Cancer is a serious and incurable disease. Rresearch has been devoted to cancer treatment for many years using a diverse of different treatment methods. However, traditional cancer therapies have many serious side effects. Bionanomaterials have the advantages of small volume, good biocompatibility and good biodegradability. Therefore, bionanomaterials have good application prospects in cancer treatment. Bionanomaterials can be used as cancer vaccines, checkpoint proteins inhibitors and the tumor microenvironment modulators for the cancer immunotherapy. Besides, bionanomaterials with photothermal conversion capacity can be prepared and used for photothermal cancer therapy. Although the number of the cancer therapies based on nanomaterials is increasing, the shortcomings of this type of cancer therapy such as low targeting abilities, large side effects and few clinical applications are still evident. The research summarizes the application of bionanomaterials in cancer immunotherapy and cancer photothermal therapy, and their limitations and future development directions will be analyzed.
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Zongzheng Wang "Application of bionanomaterials for cancer therapy", Proc. SPIE 12179, Second International Conference on Medical Imaging and Additive Manufacturing (ICMIAM 2022), 121790I (10 June 2022); https://doi.org/10.1117/12.2637325
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Cancer

Tumors

Nanomaterials

Oncology

Nanoparticles

Proteins

Iron

Back to Top